Serum amyloid A is a sensitive marker of reduced activity in arthritic hamsters

References

• Kushner I. The acute phase response: from Hippocrates to cytokine biology. Eur Cytokine Net 1991; 2: 75–80
   Google Scholar
• Pepys M, de Beer F, Dyck R, Hind C, Lanham J, Fagan E, Maton P, Starke I, Fox K, Allan R, Hodgson H, Chadwick V. Clinical measurement of serum C-re-active protein in the monitoring and differential diagnosis of inflammatory diseases and tissue necrosis and in the recognition and management of intercurrent infection. Ann NY Acad Sci 1982; 389: 459–460
   Google Scholar
• Kushner I, Mackiewicz A. Acute phase proteins as disease markers. Disease Markers 1987; 5: 1–11
   PubMed Web of Science ®Google Scholar
• Mallya R K, de Beer F C, Berr H, Hamilton E DB, Mace B EW, Pepys M B. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982; 9: 3224–3228
   Web of Science ®Google Scholar
• Sipe J D. The acute phase response to inflammation. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and other plasma protein responses to tissue injury. Laboratory Diagnostic Procedures in the Rheumatic Diseases, A S Cohen. Grune and Stratton, Orlando 1985; 77–94
   Google Scholar
• Otterness I G. The value of C-reactive protein measurement in rheumatoid arthritis. Seminar Arthritis Rheum
   Google Scholar
• Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988; 17: 123–129
   PubMed Web of Science ®Google Scholar
• Dawes P T, Fowler P D, Clarke S, Fisher J, Lawton A, Shadforth M F. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986; 25: 44–49
   PubMedGoogle Scholar
• Bedell S E, Booker T B. Erythrocyte sedimentation rate. From folklore to facts. AmJMed 1985; 78: 1001–1009
   Google Scholar
• Shearn M A, Kang I Y. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986; 13: 297–298
   PubMed Web of Science ®Google Scholar
• Fabry T L. Mechanism of erythrocyte aggregation and sedimentation. Blood 1987; 70: 1572–1576
   PubMedGoogle Scholar
• Poole A R, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 1990; 33: 790–799
   PubMedGoogle Scholar
• McConkey B, Crockson R A, Crockson A P. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. Q J Med 1972; 41: 115–125
   PubMedGoogle Scholar
• Koj A. Definition and classification of acute-phase proteins. The Acute Phase Response to Injury and Infection, A H Gordon, A Koj. Elsevier, Amsterdam 1985; 139–144
   Google Scholar
• Levin M, Pras M, Franklin E C. Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum protein component. J Exp Med 1973; 138: 373–380
   PubMed Web of Science ®Google Scholar
• McAdam K PWJ, Sipe J. Murine model for human secondary amyloidosis: Genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976; 144: 1121–1127
   PubMed Web of Science ®Google Scholar
• McAdam K PWJ, Elin R, Sipe J, Wolff S. Changes in human serum amyloid A and C-reactive protein following etiocholanolone-induced inflammation. J Clin Invest 1978; 66: 390–394
   Google Scholar
• Amemiya S, Yamamoto K, Sinohara H. Purification, characterization, and acute phase response of plasma alpha-1-antiproteinase in the hamster Mesocricetus auratus. Comp Biochem Physiol 1991; 100B: 293–296
   Google Scholar
• Otterness I G, Bliven M L, Milici A J, Poole A R. Comparison of mobility changes with histologic and biochemical changes during lipopolysaccharide-induced arthritis in the hamster. Am J Pathol 1994; 144: 1098–1108
   PubMed Web of Science ®Google Scholar
• Otterness I G, Milici A J, Bliven M L. Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster. Agents Actions 1994; 40: 224–227
   Google Scholar
• Otterness I G, Bliven M L, Milici A J. Mobility changes in the golden hamster after induction of an IL-1-induced arthritis. Mediat Inflam 1994; 3: 199–204
   Google Scholar
• Yamamoto K, Tsujino Y, Saito A, Sinohara H. Concentration of murinoglobulin and a-macroglobulin in the mouse serum: variations with age, sex, strain and experimental inflammation. Biochem Int 1985; 10: 463–469
   PubMedGoogle Scholar
• Sipe J, Gonnerman W, Loose L, Knapschaefer G, Franzblau C. Direct binding solid phase ELISA for serum amyloid A (SAA). J Immunol Methods 1989; 125: 125–135
   PubMed Web of Science ®Google Scholar
• Godiner N L, Jeenah M S, Coetzee G A, van der Westhuyen D R, Strachan A F, de Beer F C. Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J Immunol Method 1985; 83: 217
   Google Scholar
• de Beer M C, de Beer F C, Beach C M, Gonnerman W A, Carreras I, Sipe J D. Syrian and Armenian hamsters differ in serum amyloid A (SAA) gene expression: Identification of novel Syrian hamster SAA subtypes. J Immunol 1993; 150: 5361–5370
   PubMed Web of Science ®Google Scholar
• Kluve-Beckrman B, Long G L, Benson M D. cDNA sequence evidence for polymorphic forms of human serum amyloid A. Biochem Genet 1986; 24: 795
   Google Scholar
• Sipe J D, Woo P, Gocdberger G, Cohen A S, Whitehead A S. Characterization of two distinct serum amyloid A Gene products defined by their complementary DNAs. Amyloidosis, G G Glenner, E Osserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Press, New York and London 1986; 57–60
   Google Scholar
• Tso J Y, Sun X -H, Kao T -H, Reece K S, Wu R. Isolation and characterization of rat and human glyceral-dehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acid Res 1985; 13: 2485
   PubMed Web of Science ®Google Scholar
• Webb C F, Tucker P W, Dowton S B. Expression and sequence analyses of serum amyloid A in the Syrian hamster. Biochemistry 1989; 28: 4785–4790
   PubMedGoogle Scholar
• Chambers R E, MacFarlane C G, Wicher J T. Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann Rheum Dis 1983; 42: 665–667
   PubMedGoogle Scholar
• Chambers R E, Hutton C W, Dieppe P A, Wichter J T. Comparative study of C-reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis 1991; 50: 677–679
   Google Scholar
• Dowton S B, Holden S N. C-reactive protein (CRP) of the Syrian hamster. Biochemistry 1991; 31: 9531–9538
   Google Scholar
• Bodmer B, Siboo R. Isolation of mouse C-reactive protein from liver and serum. J Immunol 1977; 118: 1086–1089
   Google Scholar
• de Beer F, Baltz M, Mumm E, Feinstein A, Taylor J, Bruton C, Clamp J, Pepys M. Isolation and characterization of C-reactive protein and serum amyloid P-compo-nent in the rat. Immunology 1982; 45: 55–70
   PubMed Web of Science ®Google Scholar
• Otterness I G, Pazoles P P, Moore P F, Pepys M B. C-reactive protein as an index of disease activity. Comparison of tenidap, cyclophosphamide and dexamethasone in rat adjuvant arthritis. J Rheumatol 1991; 18: 505–511
   PubMed Web of Science ®Google Scholar
• Coe J E, Ross M J. Hamster female protein. A divergent acute phase protein in male and female Syrian hamsters. J Exp Med 1983; 157: 1421–1433
   Google Scholar
• Liao W SL, Stark G R. Cloning of rat cDNAs for eight acute phase reactants and kinetics of induction of mRNAs following acute inflammation. Adv Inflamm Res 1986; 10: 220–223
   Google Scholar
• Parks J, Rudel L. Metabolism of the serum amyloid A proteins (SAA) in high-density lipoproteins and chylomicrons of nonhuman primates (Vervet Monkey). Am J Pathol 1983; 112: 243–249
   PubMedGoogle Scholar
• McAdam K PJW, Anders R, Smith S, Russell D, Price M. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. Lancet 1975; II: 572–576
   Google Scholar
• Rosenthal C, Franklin E. Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest 1975; 55: 746–753
   PubMed Web of Science ®Google Scholar
• Anders R F, Natvig J B, Sletten K, Husby G, Nordstoga K. Amyloid-related serum protein SAA from three animal species: Comparison with human SAA. J Immunol 1977; 118: 229–234
   PubMed Web of Science ®Google Scholar
• Niewold T A, Tooten P CJ. Purification and characterization of hamster serum amyloid A protein (SAA) by cholesteryl hemisuccinate affinity chromatography. Scand J Immunol 1990; 31: 389–396
   PubMed Web of Science ®Google Scholar
• van de Loo F AJ, Arntz O J, Otterness I G, van den Berg W B. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 1992; 19: 348–356
   PubMed Web of Science ®Google Scholar
• van de Loo F AJ, Arntz O J, Otterness I G, van den Berg W B. Modulation of cartilage destruction in murine arthritis with anti-IL-1 antibodies. Agents Actions 1993; 39: C211–C214
   Google Scholar
• Otterness I G, Seymour P A, Golden H W, Reynolds J A, Daumy G O. The effects of continuous administration of murine interleukin-1 a in the rat. Physiol Behav 1988; 43: 787–804
   Google Scholar
• Hirano T, Matsuda T, Turner M, Miyaska N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988; 18: 1797–1801
   PubMed Web of Science ®Google Scholar
• Houssiau F A, Devogelair J P, van Damme J, de Deuxchaisnes C N. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthropathies. Arthritis Rheum 1988; 31: 784–788
   PubMed Web of Science ®Google Scholar
• Holt I, Cooper R G, Hopkins S J. Relationships between local inflammation, interleukin-6 concentration and the acute phase in arthritic patients. Eur J Clin Invest 1991; 21: 479–484
   PubMedGoogle Scholar
• Raynes J G, Eagling S, McAdam K PWJ. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 1991; 83: 448–491
   Google Scholar
• Sipe J D, Rokita H, Bartle L M, Loose L D, Neta R. The IL-1 receptor antagonist simultaneously inhibits SAA and stimulates fibrinogen synthesis in vivo and in vitro a proposed mechanism of action. Cytokine 1991; 3: 497
   Google Scholar
• van Leeuwen M A, van Rijswijk M H, van de Heijde D MFM, te Meerman G J, van Riel P LCM, Houtman P M, van de Putte L BA, Limburg P C. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993; 32: 9–13
   PubMedGoogle Scholar